Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 100 participants.
Also called NCT07149714
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 100 participants
- Registry
-
NCT07149714
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Russia
- Registry status
- Recruiting
Technical summary
Registry record NCT07149714. Allocation not applicable; no masking; primary purpose treatment. Start 2023-02-17 (actual); primary completion 2028-02-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI
- Acronym
- POTOK
- Condition
- Ischemic Cardiovascular Disease
- Condition
- Multivessel Coronary Artery Disease
- Condition
- Coronary Artery Disease
- Condition
- Cardiogenic Shock
- Condition
- Acute Heart Failure (AHF)
- Condition
- Chronic Heart Failure
- Condition
- Percutaneous Coronary Intervention
- Intervention (Device)
- iVAC 2L
- Lead sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Record details
- Record id
cardio:ct-nct07149714- Content hash
c0d3dcbe2ceff99c5a0f04641d22edc9f103353ae83e28e8fc3acb18d9375632